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ABSTRACT
Case report: A 63-year-old man with bilateral con-
junctivochalasis presented with tearing, irritation,
foreign body sensation and a delayed fluorescein
clearance test. After no symptomatic improvement
with topical treatment, surgery was carried out,
with amniotic membrane transplantation and fibrin
sealant.
Discussion: Conjunctivochalasis is a frequent
disorder that shares symptoms with dry eye syndro-
me. When there is no response to topical treatment,
surgical treatment is needed. The surgical technique
described by Tseng, and based on amniotic mem-
brane transplantation without suture, resulted in a
very useful response, due to less inflammation and
a rapid resolution and improvement of symptoms
(Arch Soc Esp Oftalmol 2007; 82: 571-574).
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SHORT COMMUNICATION
RESUMEN
Caso clínico: Paciente de 63 años que presenta una
conjuntivocalasia bilateral con lagrimeo, picor,
escozor y retraso en el aclaramiento de fluoresceí-
na. Al no observarse mejoría sintomática con el tra-
tamiento tópico, se interviene quirúrgicamente con
implante de membrana amniótica sin sutura.
Discusión: La conjuntivocalasia es una patología
frecuente con síntomas comunes a la sequedad ocu-
lar. Cuando no hay respuesta al tratamiento médico
se recurre al tratamiento quirúrgico. La técnica des-
crita por Tseng basada en el implante de membrana
amniótica sin sutura resulta muy eficaz en estos
casos debido a la poca inflamación que produce
permitiendo una rápida recuperación y mejoría sin-
tomática.
Palabras clave: Conjuntivocalasia, membrana
amniótica, pegamento de fibrinógeno, sequedad
ocular, inflamación.
INTRODUCTION 
Conjunctivochalasis is an excess of bulbar con-
junctiva mainly found between the eye globe and
the lower eyelid. It tends to be bilateral, with lower
location and is more frequent among aged patients
(1,2). The mildest forms of conjunctivochalasis
aggravate any preexisting dry eye conditions with
unstable tear film and delay in the fluorescein clea-
rance test. The most severe forms, however, may
lead to ocular exposure-related problems such as
corneal ulcers or corneal dellen.
Whenever conjunctivochalasis is non-symptoma-
tic, treatment is not required. If there are any associa-
ted symptoms, initial treatment consists of artificial
tears and night ocular occlusion aimed at reducing
night exposure and topical steroids. When topical tre-
atments fail, surgical treatment is the next option. All
the proposed surgical techniques include excision of
the redundant conjunctiva. The method usually des-
cribed is a simple excision of the redundant lower
conjunctiva and closure with absorbable sutures (3). 
Amniotic membranes are successfully used in the
reconstruction of the conjunctival and corneal sur-
face. Thanks to its anti-inflammatory properties, it
is used with good results in the reconstruction of
conjunctival surfaces during conjunctivochalasis
surgical procedures (2).
CASE REPORT 
A 63-year-old male reports symptoms including
tearing, chronic conjunctivitis and nasal congestion.
Biomicroscopic exploration revealed a marked bila-
teral conjunctivochalasis (fig. 1) with delayed fluo-
rescein clearance (FCT), an elevated basal secre-
tion, slowed down fluorescein clearance and normal
reflex tear secretion. 
The treatment prescribed consisted of artificial
tears with no added preservatives, daily palpebral
cleaning and ocular occlusion, resulting in no
improvement of symptoms. We added 0.5% preser-
vative-free methylprednisolone eye drops 3 times a
day during 2 weeks. Symptoms improved only tem-
porarily, since the symptoms reappeared as soon as
treatment was interrupted. 
Due to the persistence of the symptoms, bilateral
surgical treatment was advised and subsequently
performed according to the technique described by
Tseng. The conjunctival excess was removed under
external anesthesia. The exposed sclera was cove-
red with amniotic membrane, the basal membrane
being oriented upwards. The amniotic membrane
was folded over itself in order to spread the two
components of the fibrin glue (Tissucol®) along the
sclera and on the stromal side of the amniotic mem-
brane. Small drops of glue were then spread aided
by an anterior chamber cannula. The amniotic
membrane must be tightly stretched over the sclera
in order to guarantee a good adhesion of both tis-
sues, while the excess amniotic membrane dried.
The residual conjunctiva was glued over the mem-
brane. Postsurgical treatment consisted of 0.5%
preservative-free methylprednisolone eye drops 3
times a day and ofloxacin eye drops twice a day for
15 days. There was no need to perform a postsurgi-
cal occlusion. Biomicroscopic and symptomatic
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Fig. 1: Conjunctivochalasis before surgery. 
improvement became apparent immediately after
surgery (fig. 2), and stayed so during follow-up
months (fig. 3). 
DISCUSSION 
Conjunctivochalasis is a redundant conjunctiva
associated with a partial or total loss of Tenon’s cap-
sule. Due to their properties, amniotic membranes
can be the perfect support to reinforce the Tenon’s
capsule. The amniotic membrane stimulates the pro-
liferation and differentiation of epithelial cells, main-
taining the original epithelial phenotype and decrea-
sing scarring, vascularization and inflammation. 
The diagnosis of conjunctivochalasis is often
mistaken for dry eye, but conjunctivochalasis does
not respond to conventional dry eye treatments. It is
crucial to make a differential diagnosis between dry
eye due to a deficiency of aqueous tear secretion
and dry eye induced by conjunctivochalasis (4). 
There are several theories regarding the origin of
conjunctivochalasis. One is the mechanics theory,
which states that mechanical changes related to age
result in a chronic obstruction of the lymphatic
flow, with the subsequent lymphatic dilation that
leads to clinical conjunctivochalasis (5). 
Another significant theory is the inflammatory
theory, based on an excess degradation of the extra-
cellular matrix, with delayed tear clearance. This
leads in turn to an accumulation of degradation
enzymes in tears whose chronic inflammatory
changes result in conjunctival laxity or conjunctivo-
chalasis (1). Aided by this theory, the anti-inflam-
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Fig. 2: Biomicroscopic exploration immediately after surgery. 
Fig. 3: Biomicroscopic exploration two months after surgery. 
matory properties of the amniotic membrane allow
us to intervene directly on the source of conjuncti-
vochalasis. 
This surgical technique speeds recovery due to
the lesser postsurgical inflammation in comparison
with the suture technique. In addition to this, it
improves symptoms for both conjunctivochalasis
and the associated dry eye. Thus, it would be neces-
sary to perform a prospective study allowing for
comparison between the described technique and
the simple excision and excision associated with the
conjunctival autograft in the treatment of conjuncti-
vochalasis resistant to conventional medical treat-
ments. 
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